NCT01404572 - Taste Assessment Study of 2 Atazanavir Powder Formulations in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions

HIV

Interventions

DRUG

Atazanavir (current formulation)

Solution, oral, atazanavir 15 mg/5 mL with 10% aspartame, single dose

DRUG

Atazanavir, powder for oral use 1 (POU1)

Solution, oral, atazanavir 15 mg/5 mL with 4.2% aspartame, single dose

DRUG

Atazanavir (POU2)

Solution, oral, atazanavir 15 mg/5 mL with 4.2% aspartame and sucralose, single dose

Trial Locations (1)

Pra International, Lenexa